Specialist interest in fosfomycin remains strong. This unique antibiotic opens new horizons in the effective and safe antibiotic therapy of infections caused by resistant pathogens, including MRSA and carbapenemase-producing Enterobacteriaceae. For more details, read the new article titled "Phosfomycin Again: From Evidence of Effectiveness to Implementation in Treatment Protocols for Infections Caused by Multidrug-Resistant Pathogens."